Nationwide Fund Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-22,952
| Closed | -$1.15M | – | 666 |
|
|
2017
Q3 | $1.15M | Sell |
22,952
-26,347
| -53% | -$1.32M | ﹤0.01% | 1704 |
|
|
2017
Q2 | $2.28M | Buy |
49,299
+10,013
| +25% | +$463K | 0.01% | 1370 |
|
|
2017
Q1 | $1.39M | Buy |
39,286
+921
| +2% | +$32.5K | 0.01% | 1580 |
|
|
2016
Q4 | $480K | Sell |
38,365
-1,300
| -3% | -$16.3K | ﹤0.01% | 2193 |
|
|
2016
Q3 | $549K | Buy |
39,665
+3,801
| +11% | +$52.6K | ﹤0.01% | 2136 |
|
|
2016
Q2 | $354K | Buy |
35,864
+18,100
| +102% | +$179K | ﹤0.01% | 2328 |
|
|
2016
Q1 | $300K | Hold |
17,764
| – | – | ﹤0.01% | 2342 |
|
|
2015
Q4 | $395K | Buy |
17,764
+6,251
| +54% | +$139K | ﹤0.01% | 2234 |
|
|
2015
Q3 | $272K | Buy |
11,513
+3,000
| +35% | +$70.9K | ﹤0.01% | 2413 |
|
|
2015
Q2 | $696K | Buy |
8,513
+3,852
| +83% | +$315K | ﹤0.01% | 2061 |
|
|
2015
Q1 | $432K | Buy |
4,661
+131
| +3% | +$12.1K | ﹤0.01% | 2306 |
|
|
2014
Q4 | $183K | Buy |
4,530
+1,032
| +30% | +$41.7K | ﹤0.01% | 2678 |
|
|
2014
Q3 | $86K | Hold |
3,498
| – | – | ﹤0.01% | 3026 |
|
|
2014
Q2 | $55K | Sell |
3,498
-137
| -4% | -$2.15K | ﹤0.01% | 3094 |
|
|
2014
Q1 | $55K | Hold |
3,635
| – | – | ﹤0.01% | 2844 |
|
|
2013
Q4 | $50K | Buy |
3,635
+2,360
| +185% | +$32.5K | ﹤0.01% | 3064 |
|
|
2013
Q3 | $24K | Buy |
+1,275
| New | +$24K | ﹤0.01% | 3085 |
|